Grown Rogue International (GRIN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
20 Aug, 2025Executive summary
Achieved record quarterly revenue of $7.7M, up 23% year-over-year for the quarter ended June 30, 2024.
Adjusted EBITDA (aEBITDA) rose 21% to $2.5M, with a margin of 32.7%.
Operating cash flow before working capital changes declined 38% to $1.2M, mainly due to increased SG&A for New Jersey launch and one-time Michigan partner payments.
Expanded into New Jersey with licensing approval and increased Michigan ownership to 80%.
Reduced outstanding debt by $1.75M via convertible debenture conversion, lowering annual cash interest by $0.2M.
Financial highlights
Revenue reached $7.7M, up from $6.3M year-over-year.
aEBITDA increased to $2.5M from $2.1M, a 21% rise.
aEBITDA margin slightly decreased by 50 bps to 32.7%.
Free cash flow was $0.9M after $1.0M in New Jersey construction advances.
Net loss for the quarter was $7.6M, compared to net income of $0.3M in the prior year period, primarily due to a $7.5M unrealized loss on derivative liability.
Outlook and guidance
Anticipates New Jersey sales in Q4 2024 and Illinois sales in the second half of 2025.
Expansion strategy targets entry into one new market every 9 to 12 months.
Latest events from Grown Rogue International
- Returned to profitability with $2.5M net income, positive cash flow, and ongoing expansion.GRIN
Q2 202523 Nov 2025 - Pro Forma Revenue up 26% year-over-year, driven by yield gains and new market expansion.GRIN
Q3 202517 Nov 2025 - Q3 2024 revenue up 7% to $7.0M; New Jersey operations launched; Michigan margins improved.GRIN
Q3 202420 Aug 2025 - 2024 revenue rose 16% to $27.0M, with adjusted EBITDA up 27% and rapid New Jersey expansion.GRIN
Q4 202420 Aug 2025 - Expanding multi-state cannabis producer delivers strong growth, efficiency, and brand loyalty.GRIN
Investor Presentation20 Aug 2025 - Revenue up 7% year-over-year, but Adjusted EBITDA down 31% due to pricing pressure.GRIN
Q1 202520 Aug 2025